Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy

BACKGROUND AND AIMS: Prognostic biomarkers identifying patients with early tumor progression after local ablative therapy remain an unmet clinical need. The aim of this study was to investigate circulating miR-21 and miR-210 levels as prognostic biomarkers of HCC treated by CT-guided high-dose rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Stechele, Matthias, Link, Henrike, Hirner-Eppeneder, Heidrun, Alunni-Fabbroni, Marianna, Wildgruber, Moritz, Salvermoser, Lukas, Corradini, Stefanie, Schinner, Regina, Ben Khaled, Najib, Rössler, Daniel, Galun, Eithan, Goldberg, Shraga Nahum, Ricke, Jens, Kazmierczak, Philipp Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375621/
https://www.ncbi.nlm.nih.gov/pubmed/37507808
http://dx.doi.org/10.1186/s13014-023-02316-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375621/
https://www.ncbi.nlm.nih.gov/pubmed/37507808
http://dx.doi.org/10.1186/s13014-023-02316-2

Ejemplares similares